In Vitro Diagnostic: Becton, Dickinson and Company (BDX)

• Publication date: April 2012

Becton, Dickinson and Firms (BD) is a medical technology firm , serving large healthcare institutions, life science researchers and clinical laboratories. The industry player manufactures and sells medical devices, reagents and instrument systems used by life science researchers, healthcare institutions, clinical laboratories, pharmaceutical market and general public. It operates through three reportable business sectors , namely, Medica...

Becton, Dickinson and Firms (BD) is a medical technology firm , serving large healthcare institutions, life science researchers and clinical laboratories. The industry player manufactures and sells medical devices, reagents and instrument systems used by life science researchers, healthcare institutions, clinical laboratories, pharmaceutical market and general public. It operates through three reportable business sectors , namely, Medical, Diagnostics and Biosciences. BD Technologies conducts basic research and development activities to improve manufacturing and process methods. The firm 's products are manufactured and sold worldwide in the US, Canada, Europe, the Middle East, Africa, Japan, Asia Pacific, and Latin America. It is headquartered in New Jersey, the US.

This report is a source for data, analysis and actionable intelligence on the Becton, Dickinson and Firms portfolio of new product development . The report provides detailed analysis on each pipeline product with data on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover data on product description, function, technology, indication, and application. The report is also supplemented with a detailed industry player profile and data on clinical trials, wherever applicable.
<2>
Scope of the Research

- Detailed industry player profile with data on business description, key industry player facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the new product development , by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional data on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with data on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, industry ing and sales strategies.
- Exploit Merger and Acquisition opportunities by identifying industry players with the most innovative pipeline.
- Develop successful market-entry strategies .
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ new product development through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.

In Vitro Diagnostic Industry

Data table of Contents
Data table of Contents 2
List of Tables 3
List of Figures 4
Becton, Dickinson and Firms - Business Overview 5
Key Facts 5
Becton, Dickinson and Firms - Major Products and Services 6
Becton, Dickinson and Firms Pipeline Products by Equipment Type 21
Becton, Dickinson and Firms Pipeline Products by Development Stage 23
Becton, Dickinson and Firms Pipeline Products by Therapy Area 25
Becton, Dickinson and Firms Pipeline Products by Trial Phase 27
BD HPV Test 29
Product Status 29
Product Description 29
BD Max 6 color system 29
Product Status 29
Product Description 29
BD Max MRSA/C.Diff Assay 29
Product Status 29
Product Description 29
BD Microneedle 30
Product Status 30
Product Description 30
Product Institution Details 30
BD SurePath Plus Molecular Pap Test System 30
Product Status 30
Product Description 30
BD Viper LT System 31
Product Status 31
Product Description 31
BD Viper Trichomonas Assay 31
Product Status 31
Product Description 31
Biomarker- Breast Cancer 31
Product Status 31
Product Description 32
Biomarker- Ovarian Cancer 32
Product Status 32
Product Description 32
OcuSeal Liquid Ocular Bandage 32
Product Status 32
Product Description 33
Product Milestone 33
OcuSeal Liquid Ocular Bandage Clinical Trial 33
Product Patent Details 34
Product Institution Details 34
Becton, Dickinson and Firms - Top Competitors 35
Becton, Dickinson and Firms - Key Executives 36
Becton, Dickinson and Firms - Key Employee Biographies 37
Becton, Dickinson and Firms - Operations and Subsidiaries 38
Head Office 38
Other Locations & Subsidiaries 38
Recent Developments 41
April 26, 2011: BD Reports Sales s Of US$ 1.9 Billion In Q2 Fiscal Year Ended 2011 41
April 13, 2011: BD And Waste Management Healthcare Solutions Launch Initiative To Recycle Medical Sharps 42
February 07, 2011: BD Reports Net Income Of US$ 315.94 Mln In Q1 Fiscal 2011 42
January 24, 2011: BD And Rady Children's Hospital-San Diego Announce New Pilot Project To Reduce Environmental Impact Of Sharps Disposal 42
January 20, 2011: Several Customers Select Bloom Energy's Bloom Electrons Service 42
December 20, 2010: BD Diagnostics Facility In Mebane, North Carolina Achieves LEED Silver Certification For Green Building Design 43
December 06, 2010: Hospitals, Healthcare Providers To Benefit From New Premier Agreements For Automated Blood Culture And Mycobacterial Recovery Analyzers, Reagents, Consumables And Service 44
November 16, 2010: BD Appoints Kathy Warye As Vice President, Infection Prevention 44
November 15, 2010: Hospitals, Healthcare Providers To Benefit From New Premier Agreements For Safety IV Catheters 44
November 12, 2010: Hospitals, Healthcare Providers To Benefit From New Premier Agreements For Standard Hypodermic Products 44
Appendix 45
Methodology 45
About GlobalData 45
Contact Us 45
Disclaimer 45


List of Tables

Becton, Dickinson and Firms , Major development 1
Becton, Dickinson and Firms Key Pipeline Products by Equipment Type 1
Becton, Dickinson and Firms Key Pipeline Products by Therapy Area 1
Becton, Dickinson and Firms Key Pipeline Products by Development Stage 1
Becton, Dickinson and Firms Key Pipeline Products by Trial Phase 1
Becton, Dickinson and Firms , Major development 5
Becton, Dickinson and Firms , Major Products and Services 6
Becton, Dickinson and Firms Number of Pipeline Products by Equipment Type 21
Becton, Dickinson and Firms Pipeline Products by Equipment Type 22
Becton, Dickinson and Firms Number of Pipeline Products by Development Stage 23
Becton, Dickinson and Firms Pipeline Products by Development Stage 24
Becton, Dickinson and Firms Number of Pipeline Products by Therapy Area 25
Becton, Dickinson and Firms Pipeline Products by Therapy Area 26
Becton, Dickinson and Firms Number of Pipeline Products by Trial Phase 27
Becton, Dickinson and Firms Pipeline Products by Trial Phase 28
BD HPV Test - Product Status 29
BD HPV Test - Product Description 29
BD Max 6 color system - Product Status 29
BD Max 6 color system - Product Description 29
BD Max MRSA/C.Diff Assay - Product Status 29
BD Max MRSA/C.Diff Assay - Product Description 30
BD Microneedle - Product Status 30
BD Microneedle - Product Description 30
BD SurePath Plus Molecular Pap Test System - Product Status 30
BD SurePath Plus Molecular Pap Test System - Product Description 30
BD Viper LT System - Product Status 31
BD Viper LT System - Product Description 31
BD Viper Trichomonas Assay - Product Status 31
BD Viper Trichomonas Assay - Product Description 31
Biomarker- Breast Cancer - Product Status 32
Biomarker- Breast Cancer - Product Description 32
Biomarker- Ovarian Cancer - Product Status 32
Biomarker- Ovarian Cancer - Product Description 32
OcuSeal Liquid Ocular Bandage - Product Status 32
OcuSeal Liquid Ocular Bandage - Product Description 33
OcuSeal Liquid Ocular Bandage - Product Milestone 33
OcuSeal Liquid Ocular Bandage - Evaluation Of OcuSeal Bandage For Ocular Use 33
OcuSeal Liquid Ocular Bandage - Patent Details 34
Becton, Dickinson and Firms , Key Executives 36
Becton, Dickinson and Firms , Key Employee Biographies 37
Becton, Dickinson and Firms , Other Locations 38
Becton, Dickinson and Firms , Subsidiaries 39


List of Figures

Becton, Dickinson and Firms Key Pipeline Products by Equipment Type 1
Becton, Dickinson and Firms Pipeline Products by Equipment Type 21
Becton, Dickinson and Firms Pipeline Products by Development Stage 23
Becton, Dickinson and Firms Pipeline Products by Therapy Area 25
Becton, Dickinson and Firms Pipeline Products by Trial Phase 27

Companies Mentioned
Bayer AG
B. Braun Melsungen AG
Covidien plc
Johnson & Johnson
Bio-Rad Laboratories, Inc.
Baxter International Inc.
F. Hoffmann-La Roche Ltd.
bioMerieux S.A.